Felbamate increases phenytoin but decreases carbamazepine concentrations.
Felbamate (FBM), a novel antiepileptic drug, was observed to have opposite effects on the serum concentrations of phenytoin (PHT) and carbamazepine (CBZ). Data from two male subjects who stabilized while they received both PHT and CBZ, with serum concentration fluctuations of less than 20 and 25%, respectively, form the basis of this report. Both patients required a greater than or equal to 20% reduction in PHT dose while receiving 38-40 mg/kg/day of FBM. When FBM was tapered to less than 20 mg/kg/day, a sudden drop in PHT concentrations occurred in both patients. As PHT concentrations rose, CBZ concentrations fell in both patients. The CBZ epoxide to parent ratio increased to 0.46 and 0.39, respectively during FBM treatment. The ratios were 0.18 in both patients when not receiving FBM. CBZ concentrations returned to baseline values after FBM was discontinued. This unusual and unexpected effect of FBM on two standard antiepileptic drugs underscores the need for evaluating pharmacokinetic interactions before major drug trials.
Fuerst
R H
RH
North Dakota State University, College of Pharmacy, Fargo.
Graves
N M
NM
Leppik
I E
IE
Brundage
R C
RC
Holmes
G B
GB
Remmel
R P
RP
D002220:Carbamazepine / Q000097:blood*; D004347:Drug Interactions; D000078328:Felbamate; D006801:Humans; D008297:Male; D048448:Phenylcarbamates; D010672:Phenytoin / Q000097:blood*; D011409:Propylene Glycols / Q000494:pharmacology*
D048448:Phenylcarbamates; D011409:Propylene Glycols; D002220:Carbamazepine; D010672:Phenytoin; D000078328:Felbamate